+65.8%
EMR vs XPO
+262.4%
-196.6%
-29.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | XPO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.2% | -3.1% | +1.9% | -0.3% |
| 7D | +0.9% | -0.9% | +1.8% | +1.2% |
| 30D | -5.0% | -8.1% | +3.1% | -2.5% |
| 3M | +5.9% | -19.0% | +25.0% | +12.6% |
| 6M | +7.3% | -5.2% | +12.5% | +8.5% |
| YTD | +14.6% | +35.6% | -21.0% | +3.9% |
| 1Y | +15.6% | +41.1% | -25.5% | +3.0% |
| 3Y | +60.2% | +157.9% | -97.7% | +17.1% |
| 5Y | +65.8% | +265.6% | -199.8% | +6.2% |
| All | +65.8% | +262.4% | -196.6% | +6.2% |
Cumulative growth
Daily Returns
Daily percentage return beside XPO.
Daily Out/Under-Performance
Portfolio return minus XPO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × XPO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded XPO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling